Disclosing Pleiotropic Effects during Genetic Risk Assessment for Alzheimer’s Disease: A Randomized, Controlled Trial

BACKGROUND: Increasing use of genetic testing raises questions about disclosing secondary findings, including pleiotropic information. OBJECTIVE: To determine the safety and behavioral impact of disclosing modest associations between APOE genotype and coronary artery disease (CAD) risk during APOE-b...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Intern Med
Egile Nagusiak: Christensen, Kurt D., Roberts, J. Scott, Whitehouse, Peter J., Royal, Charmaine D. M., Obisesan, Thomas O., Cupples, L. Adrienne, Vernarelli, Jacqueline A., Bhatt, Deepak L., Linnenbringer, Erin, Butson, Melissa B., Fasaye, Grace-Ann, Uhlmann, Wendy R., Hiraki, Susan, Wang, Na, Cook-Deegan, Robert, Green, Robert C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4979546/
https://ncbi.nlm.nih.gov/pubmed/26810768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M15-0187
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak